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Objective: We investigated the norepinephrine transporter (NET) expression in normal and pre-eclamptic placentas and analyzed the invasion 
activity of trophoblastic cells based on norepinephrine (NE)-NET regulation.
Methods: NET and NE expression levels were examined by western blot and enzyme-linked immunosorbent assay, respectively. Trophoblast 
invasion activity, depending on NE-NET regulation, was determined by NET-small interfering RNA (siRNA) and NET transfection into the human 
extravillous trophoblast cells with or without NE treatment and invasion rates were analyzed by zymography and an invasion assay.
Results: NET mRNA was expressed at a low level in pre-eclamptic placentas compared with normal placentas and NE concentration in mater-
nal plasma increased significantly in pre-eclamptic women compared to normal pregnant women (p<0.05). NET gene upregulation and NE 
treatment stimulated trophoblast cell invasion up to 2.5-fold (p<0.05) by stimulating matrix metalloproteinase-9 activity via the phosphoino-
sitol-3-kinase/AKT signaling pathway, whereas NET-siRNA with NE treatment reduced invasion rates.
Conclusion: NET expression is reduced by inadequate regulation of NE levels during placental development. This suggests that a complemen-
tary balance between NET and NE regulates trophoblast cell invasion activities during placental development.
Keywords: Placenta; Pre-eclampsia; Norepinephrine transporter; Enzyme-linked immunosorbent assay; Small interfering RNA
Introduction
Pre-eclampsia (PE), which is one of the most common causes of 
perinatal and maternal morbidity and mortality from obstetric dis-
eases, is a multisystem disorder diagnosed by accompanying hyper-
tension, proteinuria, and edema during the second half of pregnan-
cy, and its frequency is approximately 5% of all pregnancies [1]. The 
only curative therapy for PE is termination of the pregnancy, which 
generally leads to symptom resolution [2]. Divergent opinions exist 
on the precise mechanism for the primary pathophysiological pro-
cess of PE, but the root causes start at the early stage of implantation. 
In particular, PE has the characteristic of a lack of trophoblast inva-
sion into the maternal arteries. The lack of successful invasion by ex-
travillous cytotrophoblasts inadequate to meet the endovascular re-
modeling of spiral arterioles in the maternal myometrium affects the 
physiological modification of the spiral arteries [3]. Therefore, failure 
of invasion results in low fetal perfusion [4], nutrients, and gas ex-
change toward the fetal side of the placenta and causes PE, with its 
hallmark generalized vascular endothelial dysfunction [5]. Hyperten-
sion in women with PE is due to peripheral vasoconstriction and in-
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creased blood flow resistance. During normotensive and pre-eclamp-
tic pregnancies several monoamine neurotransmitters are secreted 
from the sympathetic nervous system and are important factors in 
the pathophysiology of hypertension [6,7]. 
Norepinephrine (NE) is one of the dominant monoamine neurotrans-
mitters released during pregnancy, and higher blood levels of NE oc-
cur in gynecological diseases, including PE [6]. The norepinephrine 
transporter (NET) plays a major role as a specific uptake system for 
NE in synaptic membranes of neurons and is responsible for fast ter-
mination of NE after neuronal release [8]. The human placenta ex-
presses NET [9] and other neurotransmitter transporters [10]. More-
over, catecholamine clearance normally maintains the fetal circula-
tion and placental metabolic functions via re-uptake of NE in the ex-
tracellular space [11]. In pre-eclampsia, a decrease in NET expression 
[12] or NET blockade (e.g., use of drugs) is postulated to increase NE 
levels. In placental defects, NET’s function is physiologically valuable 
because NE is mainly regulated by NET and is associated with vaso-
constriction [12,13]. 
Decreased NET expression during early gestation contributes to a 
high NE concentration, which causes vasoconstriction of the uterine 
spiral arteries and induces an inflammatory response on the mater-
nal side [14]. These conditions suggest failure of ordinary invasion 
percolation by extravillous trophoblasts, leading to incomplete spiral 
artery vascular remodeling [15]. However, the invasion activity of tro-
phoblasts through alterations in NE and NET expression and their as-
sociations during placental development and PE are still unclear. Re-
cent studies have shown that neurotransmitters are involved in the 
regulation of cancer cell invasion (e.g., ovarian, nasopharyngeal, and 
pancreatic cancer cells) via β-adrenoceptors [16,17]. The increase in 
interstitial NE concentration is expected to lower NET function and is 
associated with the downregulation of myocardial β-adrenoceptors 
[18]. 
The purposes of this study were to determine NET and NE expres-
sion patterns in normal placentas compared to pre-eclamptic pla-
centas and to examine the invasive potential of a first-trimester ex-
travillous trophoblast cell line (i.e., HTR-8/SVneo) using cDNA-NET 
upregulation and small interfering RNA (siRNA)-based NET down-
regulation. Furthermore, we analyzed the expression pattern of ma-
trix metalloproteinases (MMP-2 and MMP-9) involved in the invasion 
ability of extravillous cytotrophoblasts.
Methods
1. Collection of placental tissues
The collection and use of samples for the study was approved by 
the institutional review board of CHA General Hospital, and informed 
consent was obtained from all patients prior to sample collection. All 
women included in our sample underwent elective cesarean sections 
without labor to avoid the effect of labor. Normal placenta and blood 
were collected from normal pregnant women who had uncomplicat-
ed pregnancies (≥37 gestational weeks). PE was diagnosed based 
on hypertension, proteinuria, and edema (Table 1). Hypertension 
was defined as a systolic blood pressure of 140 mm Hg or a diastolic 
blood pressure of 90 mm Hg on at least two occasions. Proteinuria 
was defined as 2+ protein by urine dipstick or higher than 300 mg 
on a 24-hour urine collection. Placental tissues were obtained from 
the central area of the placentas from normal pregnant women in-
cluding at term (n=15, 38±2.5 weeks), with 3rd trimester PE (n=15, 
37±3.4 weeks), and with 2nd trimester PE (n=11, 33±3.3 weeks). 
The tissues were snap-frozen in liquid nitrogen and stored at -80°C 
until use. Additionally, blood samples were collected before delivery 
and separated for the plasma and red blood cell layers by centrifuga-
tion; the plasma was transferred to a new tube and stored at -70°C 
until use.
2. Cell culture
The human extravillous trophoblast cell line HTR-8/SVneo was pro-
vided by Dr. Charles H. Graham and cultured as previously described 
[19]. Cells were cultured in RPMI-1640 medium supplemented with 
5% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL strepto-
mycin (Gibco-BRL, Grand Island, NY, USA) at 37°C in a humidified 5% 
CO2, 95% air atmosphere. 
3. Cell viability assay post NE treatment
For all experiments, up to 70% confluent cells were incubated for 
24 hours prior to drug administration. NE (Sigma, St. Louis, MO, USA) 
was stored in serum-free medium at -20°C. After NET upregulation or 
downregulation for 24 hours, cells (NE-HTR8) were exposed to NE for 
24 hours. HTR8 cells’ viability was measured using 0.4% trypan blue 
(Gib co-BRL) for 3 minutes. Blue-stained cells were considered nonvi-
able, whereas unstained cells were considered viable. Treated cells 
were counted separately on a hemocytometer under an inverted mi-
croscope.
Table 1. Maternal age and severity in normal and preeclamptic preg-
nancies
Groups Maternal 
age (yr)
Gestation-
al weeks
(±day)
Blood pressure 
(SBP/DBP)
Proteinuria 
(mg/24 hr, 
or dipstick)
Normal (n=15) 34±2 38±2.5 115±3/72±2 N
2nd trimester PE (n=11) 33±1.4 33±3.3 154±5/101±4 2.5+
3rd trimester PE (n=15) 30.2±1.1 37±3.4 134±7/91±2 2.3+
SBP, systolic blood pressure; DBP, diastolic blood pressure; N, negative; PE, 
pre-eclampsia.  http://dx.doi.org/10.5653/cerm.2013.40.1.12
  Clin Exp Reprod Med 2013;40(1):12-22
14
4. NET expression in HTR-8/SVneo cells 
Full-length NET cDNA was inserted into the pcDNA3.1/V5 expres-
sion vector (Invitrogen, Carlsbad, CA, USA). This expression vector 
(NET-pcDNA) was constructed as previous reports [20]. The NET plas-
mid was transfected into HTR-8/SVneo cells using Lipofectamine 2000, 
according to the manufacturer’s instructions (Invitrogen). To analyze 
the loss of NET function, HTR-8/SVneo cells were cultured at 50% to 
60% confluence and transfected with the NET-siRNA duplex (NET-
siRNA) or a negative control (Bioneer, Daejeon, Korea). The NET-spe-
cific target sequences used in the study were 5’-GAUUUCGUGACU-
GUAGUUU-3’ (sense) and 5’-AAACUACAGUCACGAAAUC-3’ (antisense). 
Otherwise, the negative control-specific target sequences were 5’- 
CCUACGCCACCAAUUUCGU-3’ (sense) and 5’-ACGAAAUUGGUGGC-
GUAGG-3’ (antisense). Cells were transfected with NET-siRNA or a ne-
gative control using Lipofectamine 2000, according to the manufac-
turer’s instructions. Cells or medium were harvested and analyzed 24 
hours after transfection. 
5. Cell invasion assay
Cell invasion was performed in a 24-well cell culture insert system 
(8-µm pore size, Becton Dickinson Labware, Bedford, MA, USA). Cells 
(2.5×10
4) were seeded into the upper chamber. After a 24-hour in-
cubation, the remaining cells in the upper chamber were completely 
removed with a cotton swab, and the invading cells on the bottom 
surface were fixed with absolute methanol and stained with Mayer’s 
hematoxylin (Dako, Produktionsnej, Glostrup, Denmark). The number 
of stained cells on the membranes was counted in five randomly non-
overlapping fields at a magnification of ×100. 
6. Semiquantitative reverse transcription-polymerase chain 
reaction
Total RNA was extracted from the cells and frozen tissue using TRI-
zol reagent (Invitrogen). The cDNA synthesis was performed using 
SuperScript III Reverse Transcriptase and total RNA (1 µg), according 
to the manufacturer’s instructions (Invitrogen). Polymerase chain re-
action (PCR) reactions were conducted in a T3000 Thermocycler (Bio-
metra, Goettingen, Germany) under the following conditions: dena-
turation at 95°C for 15 minutes, amplification at 95°C for 20 seconds, 
annealing at the appropriate temperature for each set of primers for 
40 seconds, extension at 72°C for 40 cycles at 1 minute each, and ter-
mination at 72°C for 5 minutes. The PCR primers used in the amplifica-
tions were as follows: hNET, 5’-TGAAGACATCAGGAAAGGTGGTG-3’ 
(sense) and 5’-CAATCAATACTCCAAATCCAGCCC-3’ (antisense); 28S 
rRNA, 5’-TTGAAAATCCGGGGGA GAG-3’ (sense) and 5’-ACATTGTTC-
CAACATGCCAG-3’ (antisense). The PCR products were electropho-
resed on 1.5% agarose gels. A semiquantitative evaluation was visu-
alized using a Gel DOC XR Molecular Imager (Bio-Rad, Hercules, CA, 
USA), and the density value of the PCR products was measured using 
Quantity One software ver. 4.6 (Bio-Rad). All experiments were per-
formed in triplicate.
7. Western blot analysis
Cell and placental tissues were homogenized and lysed with cold 
ProteoJET Mammalian Cell Lysis Reagent (Fermentas, Burlington, ON, 
Canada) supplemented with a complete protease inhibitor cocktail 
(Roche, Grenzacherstrasse, Basel, Switzerland) according to the man-
ufacturers’ instructions. Total protein was extracted using two sonica-
tion cycles (Sonics & Materials, Newtown, CT, USA) at an amplitude of 
50 for 15 seconds and then cleared by centrifugation at 15,000 rpm 
at 4°C for 15 minutes. The total protein (20-30 µg) was separated by 
10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and transferred to a PVDF membrane (Bio-Rad). After 
blocking with 7% skim milk solution, the membranes were incubat-
ed with one of the following primary antibodies: rabbit anti-NET (1: 
2,000, Chemicon, Temecula, CA, USA), rabbit anti-phosphorylated 
AKT (ser473) (1:1,000, Cell Signaling Technology, Danvers, MA, USA), 
mouse anti-phosphorylated ERK 1/2 (1:2,000, Cell Signaling Technol-
ogy), rabbit anti-phosphorylated Stat3 (Try-705) (1:500, Cell Signal-
ing Technology), and mouse anti-actin (1:5,000, Santa-Cruz Biotech-
nology, Santa Cruz, CA, USA) at 4°C overnight, followed by an incuba-
tion with horseradish peroxidase-conjugated goat anti-rabbit (1:3,000, 
Bio-Rad) or goat anti-mouse (1:10,000, Bio-Rad) secondary antibody. 
After five washings, the bands were detected using chemilumines-
cence reagent (Amersham Bioscience, Little Chalfont, Buckingham-
shire, UK). The experiments were repeated at least twice.
8. Enzyme-linked immunosorbent assay
The concentrations of total NE, total NE in maternal blood plasma 
and conditioned medium, and placental total protein were deter-
mined using a commercial ELISA (Labor Diagnostika Nord GmbH, 
Nordhorn, Germany) according to the manufacturer’s instructions. 
Conditioned medium from HTR8 cells was collected at 24 hours fol-
lowing NET gene upregulation or downregulation to determine the 
endogenous NE concentration. The supernatants were centrifuged 
at 12,000 rpm for 3 minutes at 4°C to remove debris, and the cleared 
supernatants were stored (-80°C). All experiments were performed in 
triplicate.
9. Gelatin zymography
NET-siRNA and NE treatments of HTR8 cells were assayed by zymo-
graphy to determine the level of MMP activity in NET-pcDNA condi-
tioned medium. The cells (2.0×10
5) were seeded into 6-well culture 
dishes, and the conditioned medium was collected at 24 hours. For 
each aliquot, 30 µL was separated on 12% SDS-PAGE containing 1 www.eCERM.org
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mg/mL gelatin (Sigma). After electrophoresis, the gels were washed 
twice for 15 minutes in a renaturation buffer (Bio-Rad), rinsed briefly 
with water, and incubated overnight at 37°C in a development buffer 
(Bio-Rad). Subsequently, the gels were stained for 1 hour at room 
temperature with Coomassie Brilliant Blue R-250 in 10% acetic acid/ 
40% methanol, destained in 10% acetic acid/40% methanol, and then 
dried between cellophane sheets. MMP activities were detected as 
the density of the unstained band. 
10. Statistics
We used SAS software (SAS Institute Inc., Cary, NC, USA) for statistical 
analyses. The results are presented as means±SE. All of the experi-
ments were analyzed using analysis of variance followed by Tukey’s 
multiple comparison test or Scheffe’s multiple comparison test with 
p<0.05 for significance.
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Figure 1. The expression of NET and NE in placental tissues and maternal blood. (A) NET mRNA expression (upper) and densitometric analysis 
(lower) in placental tissues using semi quantitative reverse transcription-polymerase chain reaction. NET mRNA expression was normalized to 
the amount of 28S rRNA and ispresented in a box plot. The expression levels of NET mRNA were more significantly reduced in a pre-eclamptic 
placenta than a normal placenta. Significant differences are indicated by 
ap<0.05 vs. normal. Data are expressed as the means±SE. of three 
separate experiments in duplicate. (B) NET expression in normal and pre-eclamptic placental tissues using western blot analysis. GAPDH was 
used as an internal control. (C) The NE concentration in maternal plasma between normal and pre-eclamptic pregnancies. The NE concentra-
tion increased significantly more in pre-eclamptic pregnancies than normal pregnancies. (D) The NE expression in placental tissues in normal 
and pre-eclamptic pregnancies. No difference was observed in each group. Significant differences are indicated by 
ap<0.05 vs. normal or 2nd 
PE. Columns, average value for triplicate experiments; NE, norepinephrine; NET, norepinephrine transporter; PE, pre-eclampsia; 2nd PE, second 
trimester pre-eclampsia; 3rd PE, third trimester pre-eclampsia.   http://dx.doi.org/10.5653/cerm.2013.40.1.12
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Results
1. Analysis of NE and NET expression in maternal blood and 
placental tissues
We conducted reverse transcription-polymerase chain reaction (RT-
PCR) and western blot analyses to analyze NET expression in placen-
tal tissues. The NET expression in 2nd-PE and 3rd-PE placental tissues 
decreased significantly compared to 3rd trimester normal placental 
tissues (p<0.001) (Figure 1A). Otherwise, no differences were ob-
served between the 2nd PE and 3rd PE. Similar to RT-PCR results, NET 
expression decreased more in 2nd PE than normal placental tissues 
(Figure 1B). Also, NET expression was localized in cytotrophoblasts 
and chorionic villi syncytiotrophoblasts (data not shown). These find-
ings indicate that cellular NET mRNA expression decreased in women 
with PE compared to normal women, but that the expression seemed 
likely to affect posttranslational regulation. Next, we determined NE 
expression in maternal blood plasma and placental tissue by ELISA. 
As shown in Figure 1C, plasma NE concentrations in the 3rd trimester 
were significantly higher in the PE group than in the normal group. 
Furthermore, plasma NE concentrations in the 3rd PE were signifi-
cantly higher than those of the 2nd PE (p<0.05). Placental NE expres-
sions were higher in the PE group than in the normal group, but the 
difference was not significant (Figure 1D). 
2. NET expression depends on HTR-8/SVneo cell gene-
regulation 
pcDNA-NET or siRNA-NET was transfected into HTR-8/SVneo cells 
and analyzed by RT-PCR and western blot analyses to investigate the 
NET functions dependent on gene regulation. As shown in Figure 2A, 
NET expression (RNA and protein levels) increased compared to the 
mock group when 1 µg/mL of pcDNA-NET was transfected into HTR-
8/SVneo cells (Figure 2A). Moreover, both NET RNA and protein levels 
decreased when 50 pmole of siRNA-NET were transfected into HTR-
8/SVneo cells (Figure 2B). Furthermore, the viability of HTR-8 cells 
was significantly higher in 0.5 and 1 µg/mL of pcDNA-NET compared 
to the mock group (p<0.05) (Figure 2C). However, no difference in 
the viability of HTR-8/SVneo cells was observed following the knock-
down of NET by siRNA-NET (Figure 2D). Therefore, the optimal con-
centrations of pcDNA-NET and siRNA-NET that did not affect cell via-
bility were 0.1 µg/mL and 50 pM/mL, respectively. These findings 
NET
28S rRNA
NET
β-actin
M  25  50 siNET (pM/mL)
230 bp
100 bp
55 kD
37 kD
NET
28S rRNA
NET
β-actin
M  0.1  0.5  1 pcDNA-NET (μg/mL)
230 bp
100 bp
55 kD
37 kD
A
C D
B
7
6
5
4
3
2
1
0
N
o
.
 
o
f
 
c
e
l
l
s
 
(
×
1
0
5
)
pcDNA-NET (μg/mL)
  M  0.1  0.5  1.0
a
a
4
3
2
1
0
N
o
.
 
o
f
 
c
e
l
l
s
 
(
×
1
0
5
)
siNE T (pM/mL)
  M  25  50
Figure 2. NET expression affects the viability of HTR-8/SVneo cells. (A) NET expression in HTR-8/SVneo trophoblast cells following transfection 
of a vector containing NET cDNA or an empty vector, using reverse transcription-polymerase chain reaction (RT-PCR) (upper) and western blot 
analysis (lower). (B) NET expression in HTR-8/SVneo trophoblast cells by siRNA targeting NET or a scrambled sequence using RT-PCR (upper) 
and western blot (lower). 28S rRNA and β-actin were used as internal controls for RT-PCR and western blot, respectively. (C) The viability of HTR-
8/SVneo cells after transfection with NET-pcDNA in a dose-dependent manner for 24 hours. The cell viability was significantly reduced at 0.5 
and 1.0 µg/mL pcDNA-NET. (D) The viability of HTR-8/SVneo cells after transfection with siNET. Significant differences are indicated by 
ap<0.05 
vs. Mock. NET, norepinephrine transporter; Columns, average value for three independent experiments; Bar, SE; M, mock control. www.eCERM.org
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suggest that NET gene overexpression, but not NET downregulation, 
decreases viability of the HTR-8/SVneo trophoblast cell line.
3. Invasion and MMP expression in HTR-8/SVneo cells depends 
on NET expression
We conducted an invasion assay with HTR-8/SVneo cells to explore 
whether NET expression is associated with invasion activity of HTR-8/
SVneo cells under gene regulation. The number of invading HTR-8/
SVneo cells transfected with pcDNA-NET increased by 1.8-fold at 0.1 
µg/mL of pcDNA-NET compared to the mock group (p<0.05) (Figure 
3A). In contrast, the number of invading cells transfected with siRNA-
NET decreased by 50% at 50 pmole of siRNA-NET compared to the 
Figure 3. Invasion analysis and enzyme activity of HTR-8/SVneo cells affected by NET expression. (A) The pcDNA-NET concentration-depen-
dent invasion activity of HTR-8/SVneo cells. (B) The siNET concentration-dependent invasion activity of HTR-8/SVneo cells. (C) The enzyme ac-
tivity of MMP-2 (left) and MMP-9 (right) in conditioned medium due to pcDNA-NET modulation. (D) The enzyme activity of MMP-2 (left) and 
MMP-9 (right) in conditioned medium due to siRNA-NET modulation. The columns in the graph represent the intensity of MMP-2 and MMP-9 
measured in triplicate. Significant difference are indicated by 
ap<0.05 vs. Mock. The values are expressed as the means±SE of three separate 
experiments. NET, norepinephrine transporter; M, mock control; MMPs, matrix metalloproteinase.
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mock group (p<0.05) (Figure 3B). 
We collected HTR-8/SVneo supernatants from cells transfected with 
pcDNA-NET or siRNA-NET and analyzed their MMP activity using zy-
mography to investigate whether the altered invasiveness in accor-
dance with NET regulation could affect MMP expression. As shown in 
Figure 3C, MMP activities in the transfected HTR-8/SVneo cells with 
pcDNA-NET increased the activity of MMP-9 significantly at 0.1-0.5 
µg/mL of pcDNA-NET compared to the mock group. Otherwise, in-
creasing concentrations of pcDNA-NET showed a tendency to de-
crease MMP-2 activity (p<0.05) (Figure 3C). However, no differences 
in MMP-2 or MMP-9 activity occurred following NET down-regulation 
in HTR-8/SVneo cells (Figure 3D). These findings indicate that these 
alterations in NET gene expression could be causing regulation of 
trophoblast invasion through MMP-2 and -9 activities in trophoblast 
cells although their regulation mechanism is not clear. 
4. Invasion activity and NET expression of HTR8 cells following 
NE treatment 
We demonstrated that an alteration in NET expression in HTR-8/SV-
neo trophoblast cells regulated trophoblast cell invasion activities via 
control of MMP expression. NET expression and function was corre-
lated with NE concentration. Therefore, we investigated whether an 
exogenous NE treatment would affect the viability and invasion of 
HTR-8/SVneo cells and whether an association exists between the 
NE-NET balance and trophoblast cell invasion. Interestingly, there 
were no differences in the expression of the 55 kDa subunit of NET 
following NE treatment. In contrast, the expression of the 85 kDa sub-
unit of NET was increased with 0.1 and 1 µM NE treatments but de-
creased with 10 µM NE (Figure 4A). Furthermore, increased exoge-
nous NE significantly enhanced trophoblast cell viability at concen-
trations up to 1 µM (p<0.05) (Figure 4B). However, higher doses of 
NE (>20 µM) resulted in trophoblast cell death (data not shown). 
Moreover, a higher concentration of exogenous NE significantly in-
creased the trophoblast cell invasion rate at 1 to 10 µM. Cell invasive-
ness increased to a maximum of 5.2-fold when compared to the mock 
group (p<0.05) (Figure 4C). MMP-2 and MMP-9 activity increased in 
HTR-8/SVneo cells treated with NE using zymography; in particular, it 
induced a 2.5-fold peak at 10 µM NE (Figure 4D). These results sug-
gest that exogenous NE increased the proliferation of HTR-8 cells and 
invasion activity of trophoblast cells by inducing MMP activity through 
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Figure 4. Proliferation activity of HTR-8/SVneo cells and expression of the NET based on NE treatment. (A) The NET expression in HTR-8/SVneo 
cells after a 24-hour NE treatment. β-actin was used as an internal control. (B) The viability in HTR-8/SVneo cells after a 24-hour NE treatment. 
NE significantly induced an increase in cell proliferation. (C) The invasion activity of HTR-8/SVneo cells after NE treatment. (D) MMP-2 and MMP-
9 activity in HTR-8/SVneo cell medium after 24-hour incubation with NE using zymography. The columns in the graph represent the intensity 
of MMP-2 and MMP-9 measured in triplicate. Significant difference are indicated by 
ap<0.05 vs. Mock. The values are expressed as the means±SE. 
M, mock control; MMP, matrix metalloproteinase; NE, norepinephrine; NET, norepinephrine transporter. www.eCERM.org
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the regulation of NET expression. 
5. Invasion activity of HTR-8/SVneo cells depends on a balance 
between NE and NET expression
Next, we analyzed the endogenous NE clearance in conditioned 
medium via NET gene-regulation (pcDNA-NET and siRNA-NET). NE 
expression in conditioned medium by NET overexpression decreased 
significantly compared to the mock group (p<0.05). Nevertheless, 
NE expression increased significantly in the conditioned medium fol-
lowing NET knockdown (p<0.05) (Figure 5A). To determine whether 
the balance between NE and NET expression altered the invasion ac-
tivity of HTR-8/SVneo cells, we performed an invasion assay to quan-
tify HTR-8/SVneo cell invasion with NE treatment and with or without 
NET expression. As shown in Figure 5, the invasion activity of HTR-8/
SVneo cells following NE treatment stimulated the invasiveness of 
HTR-8/SVneo cells 2-fold (p<0.05). NET overexpression tended to in-
crease the invasion activity of HTR-8/SVneo cells. Furthermore, NE 
treatment and NET upregulation stimulated the invasion ability of 
HTR-8/SVneo cells more than other groups including the mock group 
(p<0.05) (Figure 5B). NET downregulation by siRNA-NET significantly 
inhibited the invasion activity of HTR-8/SVneo cells compared to the 
control (p<0.05). Furthermore, downregulating NET completely in-
hibited the increased NE-induced invasion activity of HTR-8/SVneo 
cells, which was decreased by 70% compared to the NE-only treat-
ment group (p<0.05) (Figure 5C). From these results, we confirmed 
that NE induced HTR-8/SVneo cells to increase invasiveness because 
the cells exposed to NE secreted much more MMP-2 than MMP-9. 
Additionally, the excessive concentration of exogenous NE may have 
regulated NET function and invasion activity and aided clearance of 
NE via NET. Taken together, the results suggest that the balance be-
tween NE and NET expression levels plays an important role in regu-
lating HTR-8/SVneo cell invasion activity. 
6. MMP activity via the AKT signal pathway regulate invasion 
of HTR-8/SVneo cells
We demonstrated that alteration of NET expression in HTR-8/SVneo 
cells affected MMP-2 and MMP-9 activities using zymography. There-
fore, we investigated whether NE and NET expression could be acti-
vated by MMP-2 and MMP-9 and sought to determine which signal-
ing pathways are involved. Generally, phosphoinositol-3-kinase (PI3K)/ 
AKT and the extracellular signal-regulated kinase (ERK) signaling path-
ways are involved in the migration and invasion of cancer cells [21,22]. 
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Figure 5. Invasion activity of HTR-8/SVneo cells depends on the balance between NE and NET expression. (A) The concentration of endoge-
nous NE in the medium of HTR-8/SVneo cells transfected with pcDNA-NET or siNET. The NE concentration in the medium decreased following 
NET overexpression (0.1 μg/mL); otherwise, it increased following NET downregulation (50 pM/mL) compared with the mock group. Significant 
differences are indicated by 
ap<0.05 vs. Mock and 
bp<0.05 NET vs. siNET. (B) The invasion activity of HTR-8/SVneo cells depended on a balance 
between NE and NET overexpression. Significant differences are indicated by 
ap<0.05 vs. Mock and 
bp<0.05 NE vs. NET. (C) The invasion activi-
ty in HTR-8/SVneo cells depended on a balance between NE and NET downregulation. The experiments were performed in triplicate. Signifi-
cant difference are indicated by 
ap<0.05 vs. Mock and 
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Figure 6.  PI3K/AKT and STAT3 signaling pathways in HTR-8/SVneo 
cells exposed to 50 ng/mL EGF, NE, and NET alterations. PI3K/AKT and 
STAT3 signaling pathways were analyzed by the combination with 
NET, NE, and siNET in HTR-8/SVneo cells. β-actin was used as an inter-
nal control. NE, norepinephrine; NET, norepinephrine transporter; EGF, 
epidermal growth factor.
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Thus, we analyzed the phosphorylated PI3K/AKT and STAT3 path-
ways and MMP-2 and MMP-9 activity in HTR-8/SVneo cells based on 
the alteration of NE-NET expression. As shown in Figure 6, the PI3K/
AKT and STAT3 signaling pathways were phosphorylated in HTR-8/
SVneo cells exposed to 50 ng/mL epidermal growth factor (EGF). NET 
overexpression induced PI3K/AKT and STAT3 phosphorylation similar 
to that of EGF treatment; otherwise, NE treatment reduced this phos-
phorylation. Moreover, downregulated NET and the combination of 
NE and NET showed a tendency to drop compared to the NET-over-
expressing group (Figure 6). Therefore, NET upregulation in HTR-8/
SVneo trophoblastic cells could be induced effectively by PI3K/AKT 
and STAT3 phosphorylation. These results suggest that a balance of 
NE-NET expression is involved in trophoblastic cell invasion. These re-
sults further support the idea that  PI3K/AKT and STAT3 phosphoryla-
tion via NET alterations play an important role in HTR-8/SVneo tro-
phoblastic cell invasion. 
Discussion
The human placenta, the most important fetal-development organ 
during pregnancy, regulates dynamic gene expression, which is rele-
vant to placental and fetal development. The balanced expression of 
various genes in the placenta acts to maintain pregnancy including 
fetal development [23]. Nevertheless, aberrant gene expression in 
the placenta induces obstetric diseases (e.g., PE or an intrauterine 
growth restriction [IUGR]) [24]. Trophoblastic cells, which are one of 
the major placental cell types, regulate early implantation and pla-
cental development through proliferation, differentiation, cell-cell 
fusion, and apoptosis [25]. It was reported that trophoblast cell growth 
and survival was regulated by several neurotrophic factors such as 
brain-derived neurotrophic factor and neurotransmitter [12-26]. In 
particular, inadequate invasiveness of the trophoblast results in infer-
tility and obstetric diseases (e.g., PE, IUGR). The invasion and apopto-
sis of trophoblastic cells is regulated by various secreting factors un-
der hypoxic conditions during early pregnancy; however, the precise 
mechanism of invasion is poorly understood [27].
NE clearance into the cytosol occurs by uptake, transport, and deg-
radation of NET. The NE concentration in the extracellular environ-
ment is controlled by the degree of NET expression. Therefore, the 
balance between NE and NET has been implicated in the pathogen-
esis of various diseases, including hypertension, PE, and depression 
[12-28]. NET selectively regulates extracellular catecholamine con-
centrations as a way of maintaining homeostasis in the placental cir-
culation. The pathological and physiological reasons for the associa-
tion of PE with NET in the placenta are still unclear [6-29]. Bzoskie et al. 
[11] showed that the ovine placenta contributes to 40% of the uter-
ine NE clearance. 
We confirmed that NET mRNA expression levels were significantly 
higher in the placental tissue from normotensive pregnancies than 
pre-eclamptic pregnancies, and that NE levels were significantly low-
er in the maternal blood of normal pregnancies than pre-eclamptic 
pregnancies. Although no difference was observed in the placental 
tissues, these results suggest that secreted NE levels were significant-
ly higher during a pre-eclamptic pregnancy than a normal pregnan-
cy. However, the NET alteration in trophoblastic cells could be due to 
regulated synthesis and secretion of NE. These findings are well mat-
ched with previous reports. In an in vitro system using HTR-8/SVneo 
trophoblastic cells, we also demonstrated that reduced NET expres-
sion during PE increased the NE concentration in placental circula-
tion, whereas NET upregulation in HTR8 cells presented an inverse 
result. Furthermore, we found that altering NET expression regulated 
trophoblastic cell invasion and NE clearance. Therefore, it might be 
assumed that to avoid constriction of uterine spiral arteries and main-
tain circulatory homeostasis, trophoblastic cells cleared excessive NE 
from the maternal blood. Thus, early gestational trophoblast cells lack 
the ability to clear NE in the pre-eclamptic environment. 
This is the first report to substantiate a correlation between the NET 
level, NE concentration, invasion activity in first-trimester trophoblast 
cells, and MMP-2 and MMP-9 activity. We found that transfecting 
HTR8 cell lines with pcDNA-NET or siRNA-NET resulted in increased 
and decreased invasion activity, respectively. Placental trophoblast 
cells have the capacity to synthesize NE [6], and an uptake system for 
NE has been described on the brush border membranes of placental 
cells [30]. Therefore, when the NET gene is downregulated, HTR-8/
SVneo trophoblastic cells lack regulation of endogenous NE, which 
may be related to insufficient invasion of the trophoblast to spiral ar-
teries and affect inadequate uterine spiral artery remodeling. pcDNA-
NET or siRNA-NET could be regulating MMP-2 and MMP-9 activities. 
Although MMP-2 and -9 are derived from different genes, they have 
similar structures and substrate specificities. These proteins are ex-
pressed both in invasive extravillous trophoblasts and in the placenta 
during pregnancy in humans. Because NET-downregulated HTR-8/
SVneo trophoblastic cells result in the poor clearance of endogenous 
NE, increased NE concentrations in the extracellular environment af-
fected the altered MMP expression level in trophoblastic cells, lead-
ing to decreased invasion activity. 
Invasion is a key step in physiological placentation, but little is known 
about how catecholamines affect the invasive potential of tropho-
blastic cells. NE is related to cellular invasion. In particular, various tu-
mor cells expressing high amounts of NE increase invasion activity 
and angiogenesis, which affects tumor cell metastasis [16]. We found 
that HTR-8/SVneo trophoblastic cells exposed to exogenous NE were 
more viable and showed increased invasion activity, a greater pro-
duction of factors responsible for invasion, and decreased NET pro-www.eCERM.org
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tein (approximately 85 kDa) at a high dose. NE decreases glycosylated 
NET expression via oxidative stress in a PC12 cell line [31]. Although 
we did not investigate the mechanism of NET downregulation, hu-
man trophoblastic cells reduced glycosylated NET protein at high 
doses of NE. Because of reduced expression of the NET protein due 
to excessive NE concentrations, we suggest that a variety of symp-
toms, including a decrease in NE uptake, invasion activity, and a chan-
ge in immune response, may occur during placentation, leading to 
the development of PE. NE in HTR-8/SVneo trophoblastic cells ro-
bustly increased invasion activity at a relevant dose. Furthermore, an 
alteration in MMP expression was observed at a relevant dose. MMP-
2 and MMP-9 expression and activity were promoted by phosphory-
lation of the PI3K/AKT signal pathway [21-32]. Trophoblast cells are 
highly invasive due to the secretion of extracellular proteases, such 
as MMPs, which mediate extracellular matrix degradation, and bal-
ance tissue inhibitors of metalloproteinases [33]. Decreased NET pro-
tein, due to a failure to regulate the NE concentration, causes exces-
sive NE levels in the uterus with subsequent contraction of spiral ar-
teries and insufficient invasion activity, which reduces feto-placental 
circulation and promotes PE. Our results suggest that a balance be-
tween NE and NET plays a role in invasion by modulating the expres-
sion of MMPs in trophoblastic cells. However, the correlation between 
spiral transformation in the maternal myometrium via trophoblast 
invasion and NET function should be studied in the future. 
Taken together, the results suggest that a balance between NE and 
NET may contribute to invasion of trophoblast cells through MMP 
expression via the PI3K/AKT and STAT3 signaling pathway. These find-
ings will provide useful guidelines for understanding the mechanisms 
of trophoblast invasion as well as for developing a basic understand-
ing of the function of NE and NET in gynecological diseases, includ-
ing PE.
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